TriSalus Life Sciences, Inc.

Historical 13F Holders

Symbol
TLSI
CUSIP
89680M101
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 89680M101 since 12/18/2024, newest first.

Filer % of Class Filed
First Light Asset Management, LLC 13G/A Amendment 1
10.7% 7/7/2026
Event 6/30/2026
James J. Pallotta 13G/A Amendment 1 5.2% 5/20/2026
Event 5/15/2026
First Light Asset Management, LLC 13G
8.8% 5/15/2026
Event 3/31/2026
Utmost Group Plc 13G 5.7% 5/12/2026
Event 3/31/2026
Nantahala Capital Management, LLC 13G/A Amendment 1
4.1% 11/14/2025
Event 9/30/2025
Utmost Group Plc 13G 6.8% 11/3/2025
Event 9/30/2025
Utmost Group Plc 13G/A Amendment 1 5.2% 8/19/2025
Event 6/20/2025
Utmost Group Plc 13G 0.1% 8/18/2025
Event 5/19/2025
Nantahala Capital Management, LLC 13G
5.3% 8/14/2025
Event 6/30/2025
Frankenius Equity AB 13D/A Amendment 3
14.0% 8/4/2025
Event 7/31/2025
Mats Wahlstrom 13D/A Amendment 2
6.0% 8/1/2025
Event 7/31/2025
Frankenius Equity AB 13D/A Amendment 2
20.5% 5/2/2025
Event 4/30/2025
Utmost Group Plc 13G 6.6% 1/10/2025
Event 12/30/2024
Lombard International Assurance S.A. 13G 0% 1/10/2025
Event 12/30/2024
Mats Wahlstrom 13D/A Amendment 1
9.0% 12/19/2024
Event 12/17/2024
Frankenius Equity AB 13D/A Amendment 1
20.9% 12/19/2024
Event 12/17/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 273 $1.18 k
2026 Q2 80 22.8 M $104 M
2026 Q1 86 21.0 M $84.1 M
2025 Q4 65 11.4 M $79.6 M
2025 Q3 58 9.57 M $44.5 M
2025 Q2 48 8.47 M $46.2 M
2025 Q1 35 2.95 M $16.3 M
2024 Q4 29 2.35 M $11.8 M
2024 Q3 33 2.17 M $10.0 M
2024 Q2 30 1.79 M $9.21 M
2024 Q1 29 963 k $9.39 M
2023 Q4 21 692 k $5.85 M
2023 Q3 10 137 k $699 k